MDT
US EQUITY
Health Care
Health Care Equipment
CIK: 1613103
Medtronic (MDT) Quant Factor Diagnostic & Fair Value Model
Medtronic (Ticker: MDT) is listed in the Health Care sector (Health Care Equipment). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.
$95.41
-1.22%
Latest Close (2026-10-23)
Market Cap: $122.04B
P/E Ratio: 20.9
Momentum Strength
3M / 12M
+13.29%
1M: +7.80%
12M: -0.51%
Quality (ROE)
Point-in-Time
+11.56%
Trailing Return on Equity
Technical Trend
RSI 14
66.0
SMA50: $91.37
SMA200: $88.22
Valuation Multiplier
Trailing
20.9
Moderate Valuation Corridor (15x - 30x P/E)
📊
Valuation & Multi-Factor Diagnostic
Moderate Valuation Corridor (15x - 30x P/E)
MDT trades within a typical sector multiple band (20.9x P/E), broadly aligned with trailing earnings.
⚡
Benchmark Factor Strategy
S&P 500 Momentum Alpha Strategy
This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.
📈 Daily Candlestick & Volume Quant Chart
Interactive lightweight price action & volume breakdown over recent 90 trading days.
均线多头 (MA20/50)
Piotroski F-Score: 6/9 (Moderate Financial Health)
Official Point-in-Time Financial Filing History
Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.
备案 CIK: 1613103 · 10-K 年报 / 10-Q 季报
| Form | Period End | Filing Timestamp (Point-in-Time) | Revenue | Net Income | Operating CF | EPS (Diluted) |
|---|---|---|---|---|---|---|
| 10-Q | 2026-07-31 | 2026-09-03 | $9.76B | $1.47B | $1.79B | $1.14 |
| 10-Q | 2026-04-24 | 2026-09-03 | - | - | - | - |
| 10-Q | 2025-07-25 | 2026-09-03 | $8.58B | $1.04B | $1.09B | $0.81 |
| 10-K | 2026-04-24 | 2026-06-18 | $36.36B | $4.80B | $7.33B | $3.73 |
| 10-K | 2025-04-25 | 2026-06-18 | $33.54B | $4.66B | $7.04B | $3.61 |
| 10-K | 2024-04-26 | 2026-06-18 | $32.36B | $3.68B | $6.79B | $2.76 |
| 10-Q | 2026-01-23 | 2026-02-24 | $9.02B | $1.14B | $4.76B | $0.89 |
| 10-Q | 2025-04-25 | 2026-02-24 | - | - | - | - |
💡 Methodology & Frequently Asked Questions
Key reference details regarding Medtronic (MDT) valuation multiples, momentum factors, and point-in-time filing conventions.
How should MDT's current valuation multiple be interpreted? ↓
MDT trades at a trailing P/E of 20.9x within the Health Care sector (moderate valuation corridor (15x - 30x p/e)). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.
What are MDT's key momentum and technical factor indicators? ↓
As of the latest close, MDT shows a 1-month return of +7.80%, 3-month return of +13.29%, and 12-month return of -0.51%, with a 14-day RSI of 66.0. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.
What is Point-in-Time (PIT) financial data and why does it matter for MDT? ↓
Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.
How can MDT be incorporated into systematic factor models? ↓
MDT can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.